Literature DB >> 25800797

Hypaconitine-induced QT prolongation mediated through inhibition of KCNH2 (hERG) potassium channels in conscious dogs.

Shuilin Xie1, Ying Jia1, Aiming Liu2, Renke Dai1, Lizhen Huang3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Hypaconitine is one of the main aconitum alkaloids in traditional Chinese medicines prepared with herbs from the genus Acotinum. These herbs are widely used for the treatment of cardiac insufficiency and arrhythmias. However, Acotinum alkaloids are known for their toxicity as well as their pharmacological activity, especially cardiotoxicity including QT prolongation, and the mechanism of this toxicity is not clear.
MATERIAL AND METHODS: In this study, hypaconitine was administered orally to conscious Beagle dogs, and electrocardiograms were recorded by telemetry. Pharmacokinetic studies (6h) were conducted to evaluate the relationship between QT prolongation and exposure level. HEK293 cells stably transfected with KCNH2 (hERG) cDNA were used to examine the effects of hypaconitine on the KCNH2 channel by using the manual patch clamp technique.
RESULTS: In the conscious dogs, all doses of hypaconitine induced QTcV (QT interval corrected according to the Van de Water formula) prolongation by more than 23% (67ms) of control in a dose-dependent manner. The maximum QTcV prolongation was observed at 2h after dosing. Maximum prolongation percentages were plotted against plasma concentrations of hypaconitine and showed a strong correlation (R(2)=0.789). In the in vitro study in HEK293 cells, hypaconitine inhibited the KCNH2 currents in a concentration-dependent manner with an IC50 of 8.1nM.
CONCLUSION: These data suggest that hypaconitine inhibits KCNH2 potassium channels and this effect might be the molecular mechanism underlying QT prolongation in conscious dogs.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ECG telemetry; Hypaconitine; QT prolongation; Safety assessment; hERG channels

Mesh:

Substances:

Year:  2015        PMID: 25800797     DOI: 10.1016/j.jep.2015.03.023

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Protective mechanisms of hypaconitine and glycyrrhetinic acid compatibility in oxygen and glucose deprivation injury.

Authors:  Li-Qin Wang; Yu He; Hao-Fang Wan; Hui-Fen Zhou; Jie-Hong Yang; Hai-Tong Wan
Journal:  J Zhejiang Univ Sci B       Date:  2017-07       Impact factor: 3.066

2.  Investigation into the protective effects of hypaconitine and glycyrrhetinic acid against chronic heart failure of the rats.

Authors:  Liqin Wang; Haiming Deng; Tengyu Wang; Yun Qiao; Jianbing Zhu; Mingfeng Xiong
Journal:  BMC Complement Med Ther       Date:  2022-06-16

3.  L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.

Authors:  Jianjun Wu; Xiangchong Wang; Ying Ying Chung; Cai Hong Koh; Zhenfeng Liu; Huicai Guo; Qiang Yuan; Chuan Wang; Suwen Su; Heming Wei
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

Review 4.  Relationships between the Toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the Toxicokinetics of Its Main Diester-Diterpenoid Alkaloids.

Authors:  Mengbi Yang; Xiaoyu Ji; Zhong Zuo
Journal:  Toxins (Basel)       Date:  2018-09-26       Impact factor: 4.546

Review 5.  Risk Compounds, Preclinical Toxicity Evaluation, and Potential Mechanisms of Chinese Materia Medica-Induced Cardiotoxicity.

Authors:  Jie Zhou; Fu Peng; Xiaoyu Cao; Xiaofang Xie; Dayi Chen; Lian Yang; Chaolong Rao; Cheng Peng; Xiaoqi Pan
Journal:  Front Pharmacol       Date:  2021-03-30       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.